In this study, flumequine, an antibacterial agent used to treat bacterial diseases, tended to increase the expression of CYP1A1, CYP1B1, CYP2B4, CYP2F2, and CYP4B1 following administration at a 4× dose compared to a 1× dose. This evidence concerns the gene CYP1B1 and bacterial infectious disease.